Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report)'s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $257.75, but opened at $247.05. Bio-Rad Laboratories shares last traded at $247.05, with a volume of 244 shares trading hands.
Bio-Rad Laboratories Stock Up 6.3%
The firm has a market cap of $7.14 billion, a P/E ratio of -3.45 and a beta of 0.81. The stock's 50 day simple moving average is $250.83 and its 200 day simple moving average is $271.65. The company has a debt-to-equity ratio of 0.18, a quick ratio of 4.43 and a current ratio of 5.99.
Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $2.54 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 85.16% and a positive return on equity of 4.32%. The firm had revenue of $585.40 million during the quarter.
About Bio-Rad Laboratories
(
Get Free Report)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Featured Stories
Before you consider Bio-Rad Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.
While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
